WBSMDA: Within and Between Score for MiRNA-Disease Association prediction

[1]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[2]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[3]  Yasunori Fujita,et al.  Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. , 2008, Biochemical and biophysical research communications.

[4]  Xing Chen,et al.  A novel candidate disease genes prioritization method based on module partition and rank fusion. , 2010, Omics : a journal of integrative biology.

[5]  George A. Calin,et al.  Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer , 2008, The Prostate.

[6]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[7]  Hui Yu,et al.  Predicting Drug-Target Interactions via Within-Score and Between-Score , 2015, BioMed research international.

[8]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[9]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[10]  Yadong Wang,et al.  Predicting human microRNA-disease associations based on support vector machine , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[11]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[12]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[13]  M. Latronico,et al.  Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.

[14]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[15]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[16]  P. Bork,et al.  G2D: a tool for mining genes associated with disease , 2005, BMC Genetics.

[17]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[18]  Andreas Rimner,et al.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. , 2011, Genes & development.

[19]  Peter Möller,et al.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. , 2009, Neoplasia.

[20]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[21]  Y. Hu,et al.  MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1 , 2012, PloS one.

[22]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Renato Baserga,et al.  Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells* , 2007, Journal of Biological Chemistry.

[24]  Eiji Shimizu,et al.  Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues. , 2012, Lung cancer.

[25]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[26]  Q. Cui,et al.  Principles of microRNA regulation of a human cellular signaling network , 2006, Molecular systems biology.

[27]  Qionghai Dai,et al.  Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity , 2015, Scientific Reports.

[28]  P. Bork,et al.  Association of genes to genetically inherited diseases using data mining , 2002, Nature Genetics.

[29]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[30]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[31]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[32]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[33]  Q. Cui,et al.  Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier , 2012, PloS one.

[34]  T. Kwok,et al.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.

[35]  Arndt Hartmann,et al.  The proto‐oncogene ERG is a target of microRNA miR‐145 in prostate cancer , 2013, The FEBS journal.

[36]  Xing Chen,et al.  Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA , 2015, Scientific Reports.

[37]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[38]  Bernhard Puppe,et al.  MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. , 2011, Blood.

[39]  Yun Xiao,et al.  Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. , 2014, Molecular bioSystems.

[40]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[41]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[42]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[43]  E. Wentzel,et al.  miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. , 2009, Cancer research.

[44]  Edwin Wang,et al.  Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers , 2007, Nucleic acids research.

[45]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[46]  Xing Chen.  KATZLDA: KATZ measure for the lncRNA-disease association prediction , 2015, Scientific Reports.

[47]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[48]  S. Griffiths-Jones,et al.  miRBase: microRNA Sequences and Annotation , 2010, Current protocols in bioinformatics.

[49]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[50]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[51]  Kishore Guda,et al.  The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.

[52]  Z. Hall.  Cancer , 1906, The Hospital.

[53]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[54]  A. Bittner,et al.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer , 2009, BMC Cancer.

[55]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[56]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[57]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[58]  Stefano Volinia,et al.  MicroRNA Profiles Discriminate among Colon Cancer Metastasis , 2014, PloS one.

[59]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[60]  S. Suter,et al.  Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B‐ and T‐Cell lymphomas , 2011, Genes, chromosomes & cancer.

[61]  Ryan M. Layer,et al.  Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells , 2013, Oncogene.

[62]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[63]  Peizhang Xu,et al.  MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.

[64]  Harald J. Maier,et al.  FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. , 2012, Blood.

[65]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[66]  P. Mu,et al.  MicroRNAs in Prostate Cancer: Small RNAs with Big Roles , 2015 .

[67]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[68]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[69]  Xu Ma,et al.  MiR‐185 is involved in human breast carcinogenesis by targeting Vegfa , 2014, FEBS letters.

[70]  Mohammed Al-Shalalfa,et al.  Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures , 2013, BMC Bioinformatics.

[71]  Bassem A. Hassan,et al.  Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.

[72]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[73]  B. Coiffier.  Monoclonal antibody as therapy for malignant lymphomas. , 2006, Comptes rendus biologies.

[74]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[75]  Tomohiko Ichikawa,et al.  Functional significance of aberrantly expressed microRNAs in prostate cancer , 2015, International journal of urology : official journal of the Japanese Urological Association.

[76]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[77]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.